Complete Filing Data
RedHill Biopharma Ltd. reported Cash And Cash Equivalents of $4.62 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean RedHill Biopharma Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $9.6M | $16.2M | $28.6M | $32.4M | $25.4M | $11.5M | $7.5M | $8.0M | $3.8M | $2.7M |
| Sales And Marketing Expense | $6.0M | $14.8M | $35.4M | $55.6M | $49.3M | $18.3M | $12.5M | $12.0M | $1.6M | $1.4M |
| Research And Development Expense | $1.6M | $3.5M | $7.3M | $29.5M | $16.5M | $17.4M | $24.9M | $33.0M | $25.2M | $17.8M |
| Profit Loss From Operating Activities | -$14.6M | $12.6M | -$42.8M | -$81.1M | -$63.7M | -$43.2M | -$39.3M | -$52.0M | -$30.5M | -$22.0M |
| Profit Loss | -$8.3M | $23.9M | -$71.7M | -$97.7M | -$76.2M | -$42.3M | -$38.8M | -$45.5M | -$29.4M | -$21.1M |
| Gross Profit | $4.9M | $3.1M | $28.5M | $36.4M | $27.5M | $4.0M | $5.5M | $1.9M | $101.0K | $3.0K |
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | -$3.2M | -$44.1M | $34.5M | $33.9M | $19.2M | $3.9M | $2.9M | -$2.9M | $559.0K | $693.0K |
| Cost Of Sales | $3.2M | $3.5M | $33.3M | $49.4M | $36.9M | $2.3M | $2.8M | $2.1M | ||
| Adjustments For Increase Decrease In Allowance For Deductions From Revenue | -$1.4M | -$37.2M | $17.2M | $12.4M | $17.1M | $1.3M | $310.0K | |||
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | $6.0M | $16.2M | $7.0M | $216.0K | $845.0K | $100.0K | ||||
| Adjustments For Interest Expense | $33.2M | $5.4M | $6.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $4.6M | $5.6M | $20.0M | $29.5M | $29.3M | $29.0M | $29.0M | $16.5M | $53.8M | $21.5M | $5.9M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $9.0K | $11.0K | $198.0K | $115.0K | $406.0K | $168.0K | $23.0K | $146.0K | $85.0K | $14.0K | |
| Cash Flows From Used In Operating Activities | -$9.4M | -$35.8M | -$29.2M | -$65.0M | -$48.6M | -$40.7M | -$34.5M | -$44.8M | -$28.3M | -$17.8M | |
| Cash Flows From Used In Investing Activities | -$9.0K | $4.0K | $8.3M | -$8.1M | -$35.6M | $5.2M | $5.4M | -$18.6M | $24.5M | -$21.2M | |
| Adjustments For Increase Decrease In Trade Account Payable | -$2.1M | -$952.0K | -$7.4M | $111.0K | $7.4M | $860.0K | -$1.5M | $4.7M | -$60.0K | $153.0K | |
| Adjustments For Decrease Increase In Accrued Expenses | $3.0M | -$13.4M | -$2.9M | -$3.2M | $19.3M | -$2.7M | $722.0K | $2.7M | -$98.0K | $1.7M | |
| Supplemental Information Interest Received In Cash | $131.0K | $138.0K | $84.0K | $47.0K | $414.0K | $753.0K | $728.0K | $469.0K | $408.0K | $236.0K | |
| Adjustments For Decrease Increase In Trade Account Receivable | $52.0K | $31.9M | -$2.8M | -$3.0M | -$27.4M | -$258.0K | $570.0K | -$1.4M | $99.0K | ||
| Cash Flows From Used In Financing Activities | $8.4M | $21.4M | $11.5M | $73.5M | $84.4M | $35.5M | $41.8M | $25.7M | $36.0M | $54.8M | |
| Adjustments For Decrease Increase In Other Operating Receivables | $1.6M | $274.0K | $860.0K | -$3.3M | -$368.0K | $1.4M | -$1.7M | $612.0K | $702.0K | ||
| Issue Of Equity | $314.0K | $24.3M | $8.7M | $78.5M | $23.9M | $48.1M | $41.9M | $22.2M | $30.1M | $54.7M | |
| Supplemental Information Interest Paid In Cash | $55.0K | $367.0K | $8.2M | $11.3M | $6.7M | $251.0K | |||||
| Trade And Other Current Receivables | $2.5M | $2.6M | $34.5M | $31.7M | $28.7M | $1.2M | $958.0K | $1.5M | $99.0K | ||
| Trade And Other Current Payables | $1.2M | $3.3M | $4.2M | $11.7M | $11.6M | $4.2M | $3.3M | $4.8M | $60.0K | ||
| Retained Earnings | -$414.8M | -$407.7M | -$433.9M | -$367.9M | -$280.3M | -$208.4M | -$169.1M | -$132.9M | -$89.6M | ||
| Property Plant And Equipment | $135.0K | $193.0K | $502.0K | $572.0K | $511.0K | $228.0K | $163.0K | $230.0K | $165.0K | ||
| Noncurrent Assets | $6.1M | $6.9M | $73.0M | $92.0M | $109.7M | $20.9M | $5.6M | $5.7M | $6.4M | ||
| Liabilities | $22.7M | $21.0M | $207.3M | $172.3M | $166.4M | $14.1M | $11.2M | $12.3M | $11.5M | ||
| Intangible Assets Other Than Goodwill | $5.5M | $5.6M | $65.6M | $71.6M | $87.9M | $16.9M | $5.3M | $5.3M | $6.1M | ||
| Equity And Liabilities | $18.0M | $23.0M | $158.9M | $181.2M | $180.2M | $74.1M | $62.4M | $57.3M | $74.2M | ||
| Current Prepaid Expenses And Receivables | $1.1M | $2.8M | $4.4M | $4.7M | $5.5M | $2.2M | $1.9M | $3.3M | $1.6M | ||
| Current Liabilities | $22.2M | $20.0M | $197.5M | $81.5M | $73.2M | $10.6M | $10.4M | $11.8M | $5.4M | ||
| Current Contract Liabilities | $10.7M | $47.9M | $30.7M | $18.3M | $1.3M | $958.0K | |||||
| Current Assets | $11.9M | $16.1M | $85.9M | $89.2M | $70.5M | $53.2M | $56.8M | $51.7M | $67.8M | ||
| Current Accrued Expenses And Other Current Liabilities | $10.0M | $4.6M | $17.9M | $20.9M | $24.1M | $4.3M | $7.1M | $6.0M | $3.3M | ||
| Assets | $18.0M | $23.0M | $158.9M | $181.2M | $180.2M | $74.1M | $62.4M | $57.3M | $74.2M | ||
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | -$5.0K | -$94.0K | $27.0K | -$137.0K | -$127.0K | $67.0K | |||||
| Noncurrent Liabilities | $503.0K | $995.0K | $9.8M | $90.8M | $93.1M | $3.5M | $844.0K | $448.0K | |||
| Rightofuse Assets | $302.0K | $989.0K | $6.7M | $3.7M | $5.2M | $3.6M | $1.7M | ||||
| Current Lease Liabilities | $353.0K | $718.0K | $1.0M | $1.6M | $1.7M | $834.0K | $896.0K | ||||
| Acquisition Of Right Of Use Assets By Means Of Lease Liabilities | $270.0K | $5.6M | $303.0K | $2.9M | $2.8M | ||||||
| Noncurrent Lease Liabilities | $3.0K | $455.0K | $6.4M | $2.6M | $3.8M | $3.0M | $771.0K | ||||
| Repayment Of Payable In Respect Of Intangible Asset Purchase | $6.6M | $10.9M | $7.4M | $500.0K | |||||||
| Noncurrent Restricted Cash And Cash Equivalents | $148.0K | $147.0K | $150.0K | $16.2M | $16.2M | $152.0K | |||||
| Purchase Of Intangible Assets Classified As Investing Activities | $53.4M | $35.0K | $35.0K | $1.0M | $35.0K | $1.6M | |||||
| Noncurrent Derivative Financial Liabilities | $741.0K | $2.6M | $344.0K | $448.0K | $6.2M | ||||||
| Current Payables For Purchase Of Noncurrent Assets | $11.2M | $16.6M | $17.5M | $1.0M | $2.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Working Capital | -$2.1M | $15.6M | -$8.0M | $1.2M | -$8.4M | $2.3M | -$1.4M | -$3.7M | -$553.0K | -$2.6M |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$961.0K | -$14.4M | -$9.4M | $275.0K | $142.0K | -$76.0K | $12.7M | -$37.7M | $32.2M | $15.8M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $9.0K | -$22.0K | -$76.0K | -$96.0K | $130.0K | $94.0K | -$103.0K | $367.0K | $39.0K | -$150.0K |
| Payments Of Lease Liabilities Classified As Financing Activities | $636.0K | $1.2M | $1.5M | $1.7M | $1.6M | $796.0K | ||||
| Proceeds From Issue Of Ordinary Shares | 8.3M | 14.0M | 23.8M | 78.5M | 23.9M | 36.3M | 41.9M | |||
| Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities | $475.0K | $7.9M | $11.8M | $7.5M | $17.5M | |||||
| Proceeds From Exercise Of Warrants And Options | $4.0M | $52.0K | $5.0K | $361.0K | $3.4M | $263.0K | $108.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Shares | 465.3M | 364.3M | 296.9M | 231.2M | 176.6M | 128.5M | ||||
| Basic Earnings Loss Per Share | $0.00 | $0.01 | $-0.12 | $-0.21 | $-0.21 | $-0.14 | $-0.17 | $-0.26 | $-0.23 | $-0.19 |
| Diluted Earnings Loss Per Share | $0.00 | $0.01 | $-0.12 | $-0.21 | $-0.21 | $-0.14 | $-0.17 | $-0.26 | $-0.24 | $-0.19 |
| Basic And Diluted Earnings Loss Per Share | $0.21 | $0.14 | $0.17 | $-0.26 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease Through Sharebased Payment Transactions | $1.2M | $2.2M | $5.7M | $10.2M | $4.2M | $3.0M | $2.7M | $2.2M | $1.7M | $1.4M |
| Finance Income | $8.4M | $20.9M | $13.6M | $51.0K | $270.0K | $1.3M | $678.0K | $6.5M | $1.5M | $1.1M |
| Finance Costs | $2.1M | $9.6M | $42.4M | $16.7M | $12.8M | $438.0K | $167.0K | $77.0K | $375.0K | $212.0K |
| Adjustments For Sharebased Payments | $665.0K | $1.6M | $5.7M | $10.2M | $4.2M | $3.0M | $2.7M | $2.2M | $1.7M | $1.4M |
| Adjustments For Depreciation Expense | $588.0K | $1.4M | $2.1M | $1.9M | $1.7M | $997.0K | $90.0K | $81.0K | $44.0K | $36.0K |
| Adjustments For Decrease Increase In Inventories | $738.0K | $2.4M | $3.8M | -$8.3M | -$4.6M | -$1.1M | -$116.0K | -$653.0K | ||
| Adjustments For Revaluation Of Bank Deposits | -$19.0K | $40.0K | -$118.0K | -$101.0K | -$24.0K | -$138.0K | $123.0K | $274.0K | $69.0K | |
| Finance Income Costs Net | $11.3M | -$28.8M | -$16.6M | -$12.5M | $897.0K | $511.0K | $6.4M | $1.2M | $912.0K | |
| Adjustments For Change In Investment In Current Bank Deposits Classified As Investing Activities | -$8.5M | $8.5M | -$10.2M | $2.1M | -$4.9M | $13.0M | -$36.8M | $29.5M | ||
| Issued Capital | $35.0M | $21.4M | $2.8M | $1.5M | $1.1M | $962.0K | $767.0K | $575.0K | $441.0K | |
| Inventories | $3.7M | $4.4M | $11.0M | $14.8M | $6.5M | $1.9M | $769.0K | $653.0K | ||
| Noncurrent Royalty Obligation | $500.0K | $540.0K | $750.0K | $750.0K | $750.0K | $500.0K | $500.0K | |||
| Adjustments For Gains Losses On Change In Fair Value Of Derivatives | $13.4M | $344.0K | $104.0K | $5.7M | $1.2M | $888.0K | ||||
| Share Premium | $388.4M | $382.6M | $375.2M | $293.1M | $267.4M | $219.5M | $177.4M | $150.8M | ||
| Balances With Banks | $15.0K | $8.5M | $17.0K | $10.3M | $8.3M | $13.2M | $55.0K | |||
| Increase Decrease Through Exercise Of Options | $4.0M | $52.0K | $5.0K | $361.0K | $3.5M | $263.0K | $108.0K | |||
| Purchase Of Financial Instruments Classified As Investing Activities | $4.3M | $7.0M | $21.9M | $12.2M | ||||||
| Adjustments For Amortisation Expense | $31.0K | $545.0K | $6.0M | $16.2M | $216.0K | |||||
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$94.0K | $103.0K | -$367.0K | -$39.0K | $150.0K |
Most recent annual filing with the SEC: April 10, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.